News
-
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / Other news releases
TME Pharma announces corporate strategy update with upcoming €2.6 million financing aimed at further developing therapies for cancer treatment through public offer open to shareholders. CEO Mangasarian highlights strategic goals and plans -
-
-
-
-
-
-